The Launceston General Hospital is one of the three main public hospitals in Tasmania, Australia. It is located in Launceston and serves the north of the state.

There are 308 (+ 41 day care) beds in Launceston General Hospital.

During the past decade, Launceston General Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 9 clinical trials were completed, i.e. on average, 39.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Launceston General Hospital" #1 sponsor was "Trans Tasman Radiation Oncology Group" with 9 trials, followed by "Australian and New Zealand Intensive Care Research Centre" with 7 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Advanz Pharma" with 2 trials sponsored and "Australasian Gastro-Intestinal Trials Group" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Launceston General Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 9 trials as a collaborator, "Medical Research Institute of New Zealand" with 3 trials as a collaborator, "ANZICS Clinical Trials Group" with 2 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 2 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 2 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Launceston General Hospital" are "Breast Cancer" (3 trials), "Critical Illness" (3 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials) and "Critically Ill" (2 trials). Many other conditions were trialed in "Launceston General Hospital" in a lesser frequency.

Most popular intervention types in "Launceston General Hospital" are "Drug" (39 trials), "Radiation" (10 trials), "Procedure" (5 trials), "Behavioral" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Radiotherapy" (5 trials), "Paclitaxel" (3 trials), "Bevacizumab" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Launceston General Hospital" are 46 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Launceston General Hospital". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in Launceston General Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Launceston General Hospital, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".